CONTACT
- ICPD®
43 British American Blvd.
Latham, NY 12110 - Tel: (518) 429-2600
Fax: (518) 429-2601
- ICPD Becomes a Separate Legal Entity
- ICPD Invited to Present at FDA/NIAID/IDSA Workshop on the Issues in Antibacterial Resistance and Device Development
- ICPD Announces Participation in Anti-Infective Drugs Advisory Committee for Inhalational Anthrax
- ICPD Presence Strong at Upcoming 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting
- ICPD Invited to Present at FDA Workshop on the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired and Ventilator-Associated Pneumonia
- Pre-clinical Model Predictions Made by ICPD are Validated in Infected Patients
- ICPD to Present at AAVPT-USP Co-Sponsored Workshop Exploring Developmental Approaches to Companion Animal Antimicrobials
- ICPD Announces Collaboration with Oxford University Applying Pharmacokinetics-Pharmacodynamics (PK-PD) to Tropical Diseases
- ICPD Presents Oritavancin Dose Regimen Justification for Novel Short-Course Dosing Regimens for Complicated Skin and Skin Structure Infections
- ICPD Announces Initiative to Address US Food and Drug Administration Challenge Regarding Trial Design for Community-Acquired Respiratory Tract Infections
- ICPD Presents at IDSA-FDA Co-Sponsored Community-Acquired Pneumonia Clinical Trial Workshop
- Method for the Study of Sinusitis Developed by ICPD Scientists Cited in FDA Industry Guidance
- Commentary on Drug Development by ICPD’s Dr. Sujata M. Bhavnani Published in Nature Reviews Drug Discovery
- Ambrilia Biopharma Showcases ICPD Analysis Results
- ICPD Announces Move to New Facility
- ICPD Study Examining Adverse-Drug-Event Costs Gains National Recognition
- ICPD Announces Partnership with JMI Laboratories